Latest Market Research Report 2025

The global oligonucleotide synthesis market was valued at USD 3.68 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. This growth can be attributed to a variety of factors, including the decreasing prices of sequencing technologies, which have made genetic testing, research, forensics applications, and drug development more accessible. As the cost of sequencing continues to decline, there is an increasing demand for custom-made nucleotides, which are essential for these applications. This trend has further accelerated the demand for oligonucleotide synthesis, which is a critical step in the production of these nucleotides. The COVID-19 pandemic significantly impacted many industries, and the oligonucleotide synthesis market was no exception. The global health crisis led to a surge in the demand for efficient treatments and vaccines against COVID-19, ...

  The global oligonucleotide synthesis market was estimated at a substantial USD 3.68 billion in 2023 and is poised for significant expansion, projected to grow at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. This growth trajectory can be largely attributed to the declining costs associated with sequencing technologies, which have led to an increased demand for custom-made nucleotides. These nucleotides find a wide range of applications, spanning genetic testing, research, forensic investigations, and drug development. Additionally, the ongoing impact of the COVID-19 pandemic has further amplified the need for effective treatments, driving up the demand for oligonucleotide synthesis to support vaccine development and therapeutic interventions. The landscape of genetic research and modification has been notably transformed by the advent of advanced techniques, such as CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) and high-throughput sequenci...

  The global oligonucleotide synthesis market was estimated at USD 3.68 billion in 2023 and is projected to experience robust growth at a compound annual growth rate (CAGR) of 13.21% from 2024 to 2030. One of the primary drivers of this market growth is the declining cost of sequencing technologies, which has led to an increased demand for custom-made nucleotides. These nucleotides are vital for a variety of applications, including genetic testing, research, forensic investigations, and drug development. Additionally, the COVID-19 pandemic has had a significant impact across all markets, resulting in a surge in the demand for effective treatments against the virus, which has further intensified the need for oligonucleotide synthesis. Oligonucleotide therapeutics are emerging as promising solutions for treating chronic conditions, such as cardiovascular diseases, various types of cancer, and retinal disorders. As research and technology in the field advance, new applications for oli...